Solutions
- By Diseases
- Rare Motor Neuron Diseases (MND)
- Rare Musculoskeletal Diseases
- Rare Neurological Diseases
- Rare Neurodevelopmental Disorders
- Angelman Syndrome (AS)
- Cdkl5 Deficiency Disorder
- Noonan Syndrome (NS)
- Rubinstein-Taybi Syndrome (RSTS)
- Pitt-Hopkins Syndrome (PTHS)
- Molybdenum Cofactor Deficiency (MOCOD)
- Fragile X Syndrome (FXS)
- Asphyxia Neonatorum
- Creatine Deficiency Disorders
- Cerebral Palsy
- Rett Syndrome (RTT)
- Down Syndrome
- Canavan Disease
- Rare Neurodegenerative Diseases
- Rare Neuroinflammatory Diseases
- Rare Epileptic Syndromes
- Rare Neurometabolic Diseases
- Rare Neuropsychiatric Diseases
- Rare Neurodevelopmental Disorders
- By Services
- Diagnostic Development
- Therapeutic Development
- By Mechanism of Action
- Neuroprotective Agent Development
- Glutamate Modulator Development
- Anti-neuroinflammatory Drug Development
- Antioxidant Development
- Mitochondria-targeted Drug Development
- Protein Misfolding Inhibitor Development
- Protein Aggregation Inhibitor Development
- Excitotoxicity Inhibitor Development
- Muscle Relaxant Development
- By Molecule Types
- By Mechanism of Action
- Disease Model Development
- Preclinical Research Services
- By Products
Get Free Quote
Solutions
For
research use
only. Not intended for any clinical use.